| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA656401 | F | Tested for cytotoxicity against human CEM-TK- cell line (deficient in thymidine kinase activity) | Homo sapiens | 3 | ALA1127147 | cell-based format | Scientific Literature | |
| 2. | ALA656402 | F | Tested for antiviral activity against HIV-1 infected human CEM-TK- cell line (deficient in thymidine kinase activity) | Homo sapiens | 3 | ALA1127147 | cell-based format | Scientific Literature | |
| 3. | ALA874675 | F | Tested for percent inhibition of HIV replication against human CEM-TK- cell line (deficient in thymidine kinase activity) | Homo sapiens | 1 | ALA1127147 | cell-based format | Scientific Literature | |
| 4. | ALA657406 | F | Tested for percent reduction of viable cells in human CEM-TK- cell line (deficient in thymidine kinase activity) | Homo sapiens | 1 | ALA1127147 | cell-based format | Scientific Literature | |
| 5. | ALA653283 | F | Cytotoxic concentration which is required to reduce CEM/TK- cell viability by 50%. | Homo sapiens | 6 | ALA1130413 | cell-based format | Scientific Literature | |
| 6. | ALA653284 | F | Tested in vitro for the antiviral activity in CEM/TK- cells infected with HIV-1 | Homo sapiens | 2 | ALA1150489 | cell-based format | Scientific Literature | |
| 7. | ALA653285 | F | 50% effective concentration of compound which is required to protect Thymidine kinase deficient human CEM (CEM/TK-) cells against HIV-2. | Homo sapiens | 6 | ALA1130413 | cell-based format | Scientific Literature | |
| 8. | ALA653286 | F | Compound was tested for anti-HIV-2 activity in CEM/TK- cell line | Homo sapiens | 1 | ALA1130640 | cell-based format | Scientific Literature | |
| 9. | ALA653287 | F | Compound was tested for anti-HIV-2 activity in CEM/TK- cell line. | Homo sapiens | 6 | ALA1130640 | cell-based format | Scientific Literature | |
| 10. | ALA653288 | F | Tested in vitro for the antiviral activity in CEM/TK- cells infected with HIV-1 | Homo sapiens | 2 | ALA1150489 | cell-based format | Scientific Literature | |
| 11. | ALA653289 | F | Tested in vitro for the antiviral activity in CEM/TK- cells infected with HIV-1 | Homo sapiens | 1 | ALA1150489 | cell-based format | Scientific Literature | |
| 12. | ALA653303 | F | Concentration required to protect CEM/TK cells against the cytopathicity of HIV-2 by 50% | Homo sapiens | 3 | ALA1134482 | cell-based format | Scientific Literature | |
| 13. | ALA4816817 | A | Cytotoxicity against human CEM-TK(-) cells assessed as reduction in cell viability incubated for 5 days by MTT assay | Homo sapiens | 3 | ALA4813984 | cell-based format | Scientific Literature | |
| 14. | ALA4816820 | A | Cytotoxicity against human CEM-TK(-) cells assessed as reduction in cell viability incubated for 5 days in presence of AZT by MTT assay | Homo sapiens | 1 | ALA4813984 | cell-based format | Scientific Literature | |
| 15. | ALA5121153 | F | Cytotoxicity against human CEM-TK(-) cells assessed as reduction in cell viability | Homo sapiens | 6 | ALA5120747 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!